Medications for Asthma

66 results

  • albuterol sulfate

    (Albuterol Sulfate)
    Nephron Pharmaceuticals Corporation
    Albuterol inhalation solution is indicated for relieving bronchospasm in patients aged 2 to 12 with asthma, a condition characterized by reversible obstructive airway disease.
    Medication Details
    Drug Interactions

  • albuterol sulfate inhalation solution

    (Albuterol Sulfate)
    Ritedose Pharmaceuticals, LLC
    Albuterol Sulfate Inhalation Solution is indicated for relieving bronchospasm in patients aged 2 to 12 years with asthma (reversible obstructive airway disease).
    Medication Details
    Drug Interactions

  • alvesco

    (ciclesonide)
    Covis Pharma US, Inc
    ALVESCO is indicated for the maintenance treatment of asthma in adults and pediatric patients aged 12 and older. It is not intended for the relief of acute bronchospasm or for children under 12 years of age.
    Medication Details
    Drug Interactions

  • arnuity ellipta

    (fluticasone furoate)
    GlaxoSmithKline LLC
    ARNUITY ELLIPTA is indicated for the maintenance treatment of asthma in adults and children aged 5 years and older, but is not intended for the relief of acute bronchospasm.
    Medication Details
    Drug Interactions

  • asmanex hfa

    (MOMETASONE FUROATE)
    Organon LLC
    ASMANEX® HFA is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 5 years and older. It is not intended for relief of acute bronchospasm.
    Medication Details
    Drug Interactions

  • breztri - budesonide, glycopyrrolate, and formoterol fumarate aerosol, metered

    (Budesonide, Glycopyrrolate, And Formoterol Fumarate)
    Astrazeneca Pharmaceuticals Lp
    BREZTRI AEROSPHERE is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults and asthma in patients aged 12 and older. It is not recommended for acute bronchospasm relief.
    Medication Details

  • budesonide

    (Budesonide)
    Cipla USA Inc.
    Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and prophylactic therapy in children aged 12 months to 8 years. It is not intended for the relief of acute bronchospasm.
    Medication Details
    Drug Interactions

  • budesonide

    (Budesonide)
    Sandoz Inc
    Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and prophylactic therapy in children aged 12 months to 8 years. It is not intended for the relief of acute bronchospasm.
    Medication Details
    Drug Interactions

  • budesonide

    (Budesonide)
    Teva Pharmaceuticals USA, Inc.
    Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and prophylactic therapy in children aged 12 months to 8 years. It is not intended for the relief of acute bronchospasm.
    Medication Details
    Drug Interactions

  • budesonide and formoterol fumarate dihydrate

    (Budesonide and Formoterol Fumarate Dihydrate)
    AstraZeneca Pharmaceuticals LP
    Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol is indicated for asthma treatment in patients aged 6 and older and for the maintenance treatment of COPD. It is used for patients not adequately controlled on asthma medications or requiring both an ICS and LABA, but not for acute bronchospasm relief.
    Medication Details
    Drug Interactions